Luisa Sánchez‐Lorenzo

550 total citations
23 papers, 288 citations indexed

About

Luisa Sánchez‐Lorenzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Luisa Sánchez‐Lorenzo has authored 23 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Reproductive Medicine. Recurrent topics in Luisa Sánchez‐Lorenzo's work include Ovarian cancer diagnosis and treatment (8 papers), PARP inhibition in cancer therapy (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Luisa Sánchez‐Lorenzo is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), PARP inhibition in cancer therapy (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Luisa Sánchez‐Lorenzo collaborates with scholars based in Spain, Chile and United States. Luisa Sánchez‐Lorenzo's co-authors include Antonio González-Martı́n, Paula García‐Teijido, Luis Chiva, Raquel Bratos, Toon Van Gorp, Mihai Meirovitz, Diego Salas‐Benito, Núria Álvarez, Nicoletta Colombo and René dePont Christensen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Luisa Sánchez‐Lorenzo

22 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luisa Sánchez‐Lorenzo Spain 7 190 92 67 62 44 23 288
Ahmed Kamel Egypt 5 111 0.6× 90 1.0× 123 1.8× 63 1.0× 46 1.0× 15 287
Veena S. John United States 7 142 0.7× 102 1.1× 29 0.4× 88 1.4× 58 1.3× 26 268
Federica Predolini United States 9 148 0.8× 81 0.9× 67 1.0× 47 0.8× 39 0.9× 12 275
Nicoletta Provinciali Italy 9 175 0.9× 83 0.9× 54 0.8× 23 0.4× 24 0.5× 22 308
Alessandra Bologna Italy 12 288 1.5× 118 1.3× 188 2.8× 26 0.4× 47 1.1× 37 421
Laura Matteucci Italy 6 141 0.7× 69 0.8× 55 0.8× 21 0.3× 19 0.4× 15 272
L. Cannella Italy 9 143 0.8× 70 0.8× 55 0.8× 12 0.2× 31 0.7× 26 276
Kotaro Shimura Japan 10 212 1.1× 81 0.9× 58 0.9× 19 0.3× 179 4.1× 20 365
Adela Poitevin Mexico 8 153 0.8× 94 1.0× 45 0.7× 76 1.2× 27 0.6× 11 406

Countries citing papers authored by Luisa Sánchez‐Lorenzo

Since Specialization
Citations

This map shows the geographic impact of Luisa Sánchez‐Lorenzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Sánchez‐Lorenzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Sánchez‐Lorenzo more than expected).

Fields of papers citing papers by Luisa Sánchez‐Lorenzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Sánchez‐Lorenzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Sánchez‐Lorenzo. The network helps show where Luisa Sánchez‐Lorenzo may publish in the future.

Co-authorship network of co-authors of Luisa Sánchez‐Lorenzo

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Sánchez‐Lorenzo. A scholar is included among the top collaborators of Luisa Sánchez‐Lorenzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Sánchez‐Lorenzo. Luisa Sánchez‐Lorenzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manso, Luís, Ignacio A. Romero, Luisa Sánchez‐Lorenzo, et al.. (2024). SEOM-GEICO Clinical Guidelines on cervical cancer (2023). Clinical & Translational Oncology. 26(11). 2771–2782. 7 indexed citations
2.
Sánchez‐Lorenzo, Luisa, et al.. (2024). Management challenges in low-grade serous ovarian cancer with a BRCA mutation. International Journal of Gynecological Cancer. 34(4). 631–636.
3.
4.
Sánchez‐Lorenzo, Luisa, et al.. (2023). Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer. Seminars in Oncology Nursing. 40(1). 151554–151554. 6 indexed citations
5.
Chacón, Enrique, Félix Boria, Luisa Sánchez‐Lorenzo, et al.. (2023). #389 Seneca study: staging endometrial cancer based on molecular classification. A422.1–A422. 1 indexed citations
6.
7.
Yubero, Alfonso, Carmen Salvador Coloma, Purificación Estévez-García, et al.. (2022). Clinical experience with rucaparib after prior PARPi treatment: A subanalysis from the rucaparib access program in Spain by GEICO.. Journal of Clinical Oncology. 40(16_suppl). e17598–e17598. 1 indexed citations
8.
Sánchez‐Lorenzo, Luisa, et al.. (2022). The BRCA Gene in Epithelial Ovarian Cancer. Cancers. 14(5). 1235–1235. 12 indexed citations
9.
10.
Fariñas-Madrid, Lorena, Marı́a Santacana, Andrés Redondo, et al.. (2021). 731 Biomarker analysis of the phase 2 study of pembrolizumab in combination with doxorubicin in advanced endometrial cancer: TOPIC trial/VHIO10001. A118.2–A119. 2 indexed citations
11.
González-Martı́n, Antonio & Luisa Sánchez‐Lorenzo. (2019). Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?. Cancer. 125(S24). 4616–4622. 37 indexed citations
12.
Reynés, Gaspar, Luisa Sánchez‐Lorenzo, Emilio Esteban, et al.. (2019). Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study. Cancer Chemotherapy and Pharmacology. 84(4). 781–789. 2 indexed citations
13.
Oaknin, Ana, M.J. Rubio Pérez, Andrés Redondo, et al.. (2019). A phase II study of pembrolizumab in combination with doxorubicin in advanced, recurrent or metastatic endometrial cancer. Annals of Oncology. 30. v432–v433. 2 indexed citations
14.
Sánchez‐Lorenzo, Luisa, et al.. (2017). CP-075 Prognostic factors in patients with recurrent epithelial ovarian cancer. A33.2–A33. 1 indexed citations
15.
Carmona‐Bayonas, Alberto, Andrés J. Muñoz Martín, Luisa Sánchez‐Lorenzo, et al.. (2016). First-line triplet or doublet chemotherapy for advanced gastric cancer: Analysis of 970 patients from a community practice registry. Annals of Oncology. 27. vi212–vi212. 3 indexed citations
16.
Olmos, Vanessa Pachón, Luisa Sánchez‐Lorenzo, Eva Martínez de Castro, et al.. (2015). Splanchnic vein thrombosis in ambulatory pancreatic cancer patients receiving chemotherapy.. Journal of Clinical Oncology. 33(15_suppl). e20658–e20658. 3 indexed citations
17.
Martín, Andrés J. Muñoz, Luisa Sánchez‐Lorenzo, Eva Martínez de Castro, et al.. (2014). Incidence of incidental and symptomatic venous thromboembolism (VTE) and Khorana’s score in ambulatory pancreatic cancer patients receiving chemotherapy.. Journal of Clinical Oncology. 32(15_suppl). e15187–e15187. 1 indexed citations
18.
González-Martı́n, Antonio, et al.. (2014). First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions. Drugs. 74(8). 879–889. 20 indexed citations
19.
Jiménez‐Fonseca, Paula, et al.. (2014). Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer. Clinical & Translational Oncology. 17(5). 384–392. 11 indexed citations
20.
Álvarez-Fernández, Carlos, et al.. (2013). Reduced folate carrier (RFC) as a predictive marker for response to pemetrexed in advanced non-small cell lung cancer (NSCLC). Investigational New Drugs. 32(2). 377–381. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Kamel Breakdown of academic impact, for papers by Veena S. John Breakdown of academic impact, for papers by Federica Predolini Breakdown of academic impact, for papers by Nicoletta Provinciali Breakdown of academic impact, for papers by Alessandra Bologna Breakdown of academic impact, for papers by Laura Matteucci Breakdown of academic impact, for papers by L. Cannella Breakdown of academic impact, for papers by Kotaro Shimura Breakdown of academic impact, for papers by Adela Poitevin
Rankless by CCL
2026